整合肿瘤学(英文)(Holistic Integrative Oncology) 知网目次
- 国级普刊
- 主管单位:
中国科学技术协会
- 主办单位:
中国抗癌协会
- 国际刊号:
- 国内刊号:
12-1481/R73
- 学科分类:
- 字数:
-
- 有无基金:
- 周期:
CN外文-月刊
- 特殊属性:
外文期刊
- 电话:
022-23359958-807(官网电话)
- 邮箱:
hio@caca.org.cn(官网邮箱)
- 复合因子:
0
- 综合因子:
0
- 收录:
知网目次
- 级别:
国级普刊
期刊简介
《整合肿瘤学》期刊已被查看: 次
更新频次
单位占比
一作占比
投稿指南
1、投稿方式:在线投稿。
2、官网网址:https://link.springer.com/journal/44178
3、投稿系统:
https://www2.cloud.editorialmanager.com/hion
4、主办单位官网:http://www.caca.org.cn/
(中国抗癌协会)
5、官方微信公众号:中国抗癌协会(caca_1984)
2024年4月1日星期一
Holistic Integrative Oncology (HIO)
(《整合肿瘤学(英文)》)简介
【主办单位官网信息】
http://www.caca.org.cn/system/2022/06/14/030016908.shtml
期刊名称
中文 《整合肿瘤学》
英文 Holistic Integrative Oncology (HIO)
期刊简介
Holistic Integrative Oncology(HIO)(《整合肿瘤学(英文)》)是由中国抗癌协会与Springer Nature出版集团强强联合创办的一本旗舰英文期刊。2021年10月正式创刊,2022年4月28日全面上线,是国际上第一本传播整合肿瘤学理念,关注恶性肿瘤“防-筛-诊-治-康-管”六位一体全程健康模式,覆盖肿瘤全学科研究的英文学术期刊。
主编樊代明院士,是中国工程院、美国国家医学院(外籍)、法国医学科学院(外籍)三国院士,现任中国抗癌协会理事长、亚太消化联合学会主席。HIO编委包括诺贝尔奖医学得主、中外院士及国内外知名肿瘤学专家100余名。HIO是面向全球开放的自由获取同行评议期刊,2022年为季刊,2023年为双月刊,2024年发展为月刊,设有CACA指南、专家述评、原创论著和综述四个栏目,目前读者遍及全球156个国家。
编辑部基本信息
地址 天津华苑新技术产业园区兰苑路5号A座10楼
电话 022 - 23359958-807
传真 022 - 23526512
邮箱 hio@caca.org.cn
网站 https://link.springer.com/journal/44178/
投稿指南Submission guidelines
【官网信息】
Instructions for Authors
Article Types
Holistic Integrative Oncology publishes Research, Review, Guideline, Letter and Commentary.
• Research: the articles should include 5,000~7,000 words in the main text (excluding the title page, references, figure legends, tables and figures) and have no more than 8 figures and tables in total.
• Review: the review paper should cover a wide range of the advances related to the topic and include at least 4 figures and tables, and approximately 10,000 words (not including references).
• Guideline: evidence-based, systematically developed recommendations for achieving standardized research or clinical practice, and approximately 10,000 words.
• Letter: letters provide rapid and concise report of a novel finding that is brief in nature but is of general interest to the field. There should include max 1 figure or table and less than 1200 words in the main text, and have no more than 10 references.
• Commentary: A Commentary presents discussion on an issue(s) of public interest that has broad impacts on horticulture research (e.g. policy, funding, ethics, etc.) or relevant scientific issues that have significant impacts on the wellbeing of our society. A Comment paper should have no more than 2,500 words in main text, with a maximum of 3 figure/table/diagram and 10 references. The in-text citation and references should be formatted as those described for Research Article above.
It is the Corresponding Author’s responsibility to ensure that he/she has the correct authors’ names, affiliations, addresses and author sequence when the final corrected proofs are submitted. Please keep in mind that corrections are no longer possible after online first publication. All additional corrections need the approval of the Editor-in-Chief and would result in the publication of an erratum that will be hyperlinked to the article.
Peer review policy:
This journal follows a single-blind peer reviewing procedure. Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
……
更多详情:
https://www.springer.com/journal/44178/submission-guidelines
《整合肿瘤学》同类肿瘤学期刊
-
中国肿瘤
北核,CSCD,科核,武A+,高T3
CN中文-月刊影响因子4.965
-
中国癌症杂志
北核,CSCD,科核,武A,高T3
CN中文-月刊影响因子2.588
-
中华肿瘤防治杂志
北核,科核,武A,高T3
CN中文-半月刊影响因子1.525
-
中华肿瘤杂志
北核,CSCD,科核,武A+,高T1
CN中文-月刊影响因子7.129
-
中国肿瘤生物治疗杂志
北核,科核,CSCD扩,武A,高T3
CN中文-月刊影响因子1.475
-
中国肿瘤临床
北核,CSCD,科核,武A,高T2
CN中文-半月刊影响因子1.82
-
中华放射肿瘤学杂志
北核,CSCD,科核,高T3
CN中文-月刊影响因子1.159
-
中国肺癌杂志(不收版面费审稿费)
北核,CSCD,科核,武A,高T3
CN中文-月刊影响因子2.478
常见问题
-
整合肿瘤学杂志社官网、联系方式是什么?
整合肿瘤学杂志社官网:https://link.springer.com/journal/44178
投稿网址:https://www2.cloud.editorialmanager.com/hion联系电话:022-23359958-807(官网电话)
投稿邮箱:hio@caca.org.cn(官网邮箱) -
整合肿瘤学杂志是核心期刊么?
整合肿瘤学不是核心期刊,级别是:国级普刊, 是:肿瘤学分类下的知网目次收录的期刊。
-
请问你们是整合肿瘤学杂志社吗?
我们不是《整合肿瘤学》杂志社。本站主要从事期刊信息展示与期刊推荐,不是任何杂志官网,直投稿件请联系杂志社。本站仅提供免费的学术指导、论文辅导、期刊投稿信息整理收集服务。
-
你们指导服务后可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。编辑老师会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
晋级论文能否在报纸上发表?
在学术界,论文的发表往往被视为研究者职业发展的重要一环。晋级论文,即为了获得更高职称或学术地位而撰写的学术论文,通常需在专业期刊上发表。然而,许多人可能会问